The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Vitamin D and cancer effects of 1 25 OH 2D3 and its analogs on growth control and tumorigenesis
Open accessAbstract
Today, it is well established that besides playing a crucial role in the establishment and maintenance of the calcium homeostasis in the body, the active form of vitamin D, 1,25(OH)2D3, also acts an effective regulator of cell growth and differentiation in a number of different cell types, including cancer cells. This has led to an increased interest in using 1,25(OH)2D3 in the treatment or prevention of cancer patients and to a substantial number of studies investigating the effect of 1,25(OH)2D3 on cancer cells. The results are encouraging, but clearly demonstrate that the therapeutic window of 1,25(OH)2D3 is extremely narrow due to the calcemic adverse effects of this compound. Much effort has consequently been directed into identifying vitamin D analogs with potent cell regulatory effects but with weaker effects on the calcium metabolism than those of 1,25(OH)2D3. In an attempt to clarify the mechanisms implicated in the cell regulatory effects of 1,25(OH)2D3 and eventually facilitate the process of developing new specific vitamin D analogs, numerous investigations have been carried out with 1,25(OH)2D3 and its analogs. The present review will focus on the results obtained in these studies and describe some of the synthetic analogs, which have shown to be of particular interest in relation to cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Yudoh, K., Matsuno, H., & Kimura, T. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90004-5 · Cited by 75
Cited by
The Role of Vitamin D in Cancer Prevention
Garland, C. F., Garland, F. C., Gorham, E. D., Lipkin, M., Newmark, H., Mohr, S. B., & Holick, M. F. (2006) · American Journal of Public Health · doi:10.2105/ajph.2004.045260 · Cited by 1,031
Singh, R. J., Taylor, R. L., Reddy, G. S., & Grebe, S. K. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0710 · Cited by 478
H YDROXYLASE E NZYMES OF THE V ITAMIN D P ATHWAY: Expression, Function, and Regulation
Omdahl, J. L., Morris, H. A., & May, B. K. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.120501.150216 · Cited by 311
Newton-Bishop, J. A., Beswick, S., Randerson-Moor, J., Chang, Y.-M., Affleck, P., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1135 · Cited by 295
Abbas, S., Linseisen, J., Slanger, T., Kropp, S., Mutschelknauss, E. J., Flesch-Janys, D., & Chang-Claude, J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm240 · Cited by 279
Lowe, L. C., Guy, M., Mansi, J. L., Peckitt, C., Bliss, J., Wilson, R. G., & Colston, K. W. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.017 · Cited by 256
Human pigmentation variation: evolution, genetic basis, and implications for public health
Parra, E. J. (2007) · American Journal of Physical Anthropology · doi:10.1002/ajpa.20727 · Cited by 191
Russo, I., Caroppo, F., & Alaibac, M. (2015) · Cancers · doi:10.3390/cancers7030841 · Cited by 29
Metadata
- Authors
- Hansen, C. M.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2001
- Volume
- 6
- Issue
- 3
- Pages
- d820-848
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/a645
- OpenAlex
- W2089883050
- Cited by
- 178
- References
- 2
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.